NHN Investment
Overview
NHN Investment is the venture capital investment arm of NHN Corporation, a South Korean global IT company. Founded in 2010, the firm is based in Seoul and makes early to late-stage investments in companies with high growth potential. Its investment sectors include technology, enterprise applications, life sciences, communications, mobile, and gaming.
Portfolio Companies
5
Website
nhn.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Catenoid | Mar 2013 | VC Round | Co-investor |
| Butterfast | Mar 2020 | VC Round | Co-investor |
| Avegant | Nov 2014 | Series A | Lead |
| ImmunoMet Therapeutics | Mar 2017 | Series B | Co-investor |
| iMediSync | Jun 2018 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NHN Investment based?
NHN Investment is headquartered in Seoul, Seoul, South Korea.
When was NHN Investment founded?
Founding year information for NHN Investment is not publicly available.
How many portfolio companies does NHN Investment have?
NHN Investment has 5 portfolio companies in Caplight's dataset.
What are some companies in NHN Investment's portfolio?
Portfolio companies visible on Caplight include Catenoid, Butterfast, Avegant, ImmunoMet Therapeutics, iMediSync.
What was NHN Investment's most recent investment shown here?
NHN Investment's most recent investment in this portfolio sample was in Butterfast in 2020.
What sectors does NHN Investment focus on?
NHN Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does NHN Investment focus on?
Stage focus information for NHN Investment is not publicly available.